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Abstract
THE EFFECT OF SINGLE NUCLEOTIDE 
POLYMORPHISMS (SNPs) IN TOLL-LIKE RECEPTORS -2, -4, 
-9, AND CD14 GENES IN AN AFRICAN-AMERICAN 
POPULATION WITH CHRONIC PERIODONTITIS
By Willard W. Maughan, DDS
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director:  Sinem Esra Sahingur, DDS, MS, PHD
Assistant Professor, Department of Periodontics
AIM:  to determine if a relationship exists between TLR-2, TLR-4, TLR-9, or 
CD14 polymorphisms and risk for developing chronic periodontal disease in an African-
American population. This is the first study conducted to determine role of SNPs in TLR 
genes and CD14 gene in a periodontally-diseased African-American population.
Additionally, this is the first study to assess the role of TLR-9 polymorphism in 
periodontitis patients.  METHODS:  A total of 130 subjects were involved in the study.
The chronic periodontitis (CP) group contained 73 subjects, and the healthy control (NP)
group 57subjects. Genotyping was performed in TLR2 (G2408A), TLR4 (A896G),TLR9 
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(T1486C) and CD14 (C260T)  genes by TaqMan® allelic discrimination using Assay-by-
DesignSM SNP Genotyping Assays (Applied Biosystems). Accuracy of genotyping was 
confirmed by known DNA samples of each genotype and by Polymerase Chain Reaction-
Restriction Fragment Length Polymorphism (PCR-RFLP) analyses on selected samples. 
Fisher’s exact test and chi-square analyses were performed to compare genotype and allele 
frequencies. Within disease groups, we investigated whether SNPs were related to disease 
severity by step-wise logistic regression adjusted for age, gender, and smoking status.  
RESULTS:  There was a significant difference in the distribution of specific TLR9 
(T1486C) genotypes between the periodontally diseased group versus the control group. 
Expression of TT genotype was more prevelant in periodontally-diseased individuals 
compared to periodontally-healthy subjects (p<0.0001) whereas individuals expressing C 
allele of the TLR9 SNP (CC&CT) were more frequently found in the control group after 
adjusting for age, gender, and smoking status (p<0.0001) There was no statistically 
significant difference in the distribution of genotypes between groups for any other TLRs 
or CD14 polymorphism.  CONCLUSION:  Based on findings of this study, homozygocity 
for the T allele of TLR 9 polymorphism was related to chronic periodontal disease 
susceptibility in African Americans. Additionally, presence of the C allele at TLR-9 
appeared to confer resistance to periodontal destruction.  Our results showed that specific 
SNPs in TLR-2, -4 and CD14 genes are not related to periodontitis in African Americans. 
This document was created in Microsoft Word 2007 format.
1Introduction
Periodontal disease is the result of a chronic bacterial infection involving gram-
negative anaerobic pathogens.  Bacteria colonizes on the tooth surface into biofilms (dental 
plaque) and initiates a host-driven inflammatory response leading to gingival 
inflammation.  Dental plaque contains several hundred different bacterial species, and so 
far no single periodontopathogenic species has been identified as the sole causative factor 
for periodontitis.  Initially, the biofilm consists of mainly gram positive aerobic bacteria.    
The colony then undergoes a maturing process to a predominantly gram-negative, 
facultative anaerobic aggregate.1   As the biofilm ages, this increased bacterial insult to the 
host elicits an inflammatory response.  Inflammatory response can lead to increased release 
of inflammatory mediators, including cytokines.  Increased tissue concentration of 
inflammatory cytokines can cause damage to host tissues supporting the teeth on which the 
biofilm has colonized if left untreated.  
Periodontal disease is a multifactorial response to bacterial infection which is 
influenced by individual host response, bacterial load, genetic susceptibility, and 
environment.  Numerous reports have demonstrated a close association between 
periodontal tissue destruction and the development of a complex of microbial species 
within the plaque aggregate including Porphyromonas gingivalis, Tannerella forsythia, 
Aggregatibacter (formerly Actinobacillus) actinomycetemcomitans, Treponema denticola, 
Prevotella intermedia, and Fusobacterium nucleatum.2,3,4 The process involved during this 
development was investigated by many authors.  Haffajee and Socransky studied 
organisms responsible for periodontal destruction, and created a modality for classifying 
bacterial colonizers.5  The so termed “Socransky complexes” were described as early or 
late colonizers according to the time frame in which they colonize in the plaque biofilm.6,7  
Some individuals have a greater inflammatory response to periodontal-specific 
bacteria, and experience more destruction and increased bone loss compared to the average 
2individual response.8  This increased destruction may be due to a genetic predisposition.  
Table 1 lists multiple syndromes attributed to increased susceptibility to infections.  All 
syndromes listed in table 1 also demonstrate risk of accelerated periodontal destruction.  
Genetic predisposition has been studied and reported to have an effect on host 
susceptibility to periodontal destruction.9  Support for genetic susceptibility for the more 
common forms of adult periodontitis is increasing and suggests a multifactorial disease 
pattern.  The results of twin studies clearly indicate that a significant part of the variance in 
clinical and radiographic measures of periodontitis may be explained by genetic factors.10  
Several immune response traits have been associated with clinical forms of periodontitis, 
and for some of these factors the underlying genetic determinants are known. Although it 
is unlikely that polymorphisms in all of these genetic determinants impart differential 
susceptibility to periodontal disease, it is reasonable to expect that multiple genes will be 
important and that knowledge of these may permit determination of individual 
susceptibility.57
Pathogen-associated molecular patterns (PAMPs) represent conserved bacterial 
components expressed by microorganisms that are not found in higher eukaryotic cells.11
They are recognized by toll-like receptors (TLRs) and other pattern recognition receptors 
(PRRs) in plants and animals.  Some of the periodontal bacterial-associated PAMPs 
include LPS, lipoproteins, fimbriae, and bacterial or viral DNA.12,13,14,15,16,17  PAMPs can 
activate host immune responses that may lead to increased cytokine production from
monocytes and macrophages, including IL-1, TNFα, and IL-6.11  These cytokines are 
responsible for osteoclast activation, leading to bone resorption, and ultimately resulting in 
periodontal tissue destruction.12 The balance between inflammatory and anti-inflammatory 
cytokine expression is vital in the maintenance of health.  
Toll-like receptors (TLRs) are transmembrane pattern-recognition receptors (PRRs) 
that mediate intracellular signaling and antimicrobial responses upon recognition of 
conserved PAMPs, and play a major role in nonspecific (innate) immunity.11 They contain 
an extracellular domain, and a cytoplasmic domain with homology to the mammalian IL-1 
receptor.11 TLRs recognize PAMPs that are expressed by a variety of microorganisms, 
3including pathogens known to be associated with periodontal disease,14,15 forming a 
cellular recognition barrier for PAMPs related to multiple periodontopathogenic bacteria.  
TLRs also lack memory, which is characteristic to the innate immune system.  Figure 1 
illustrates known Toll-like receptors and their cellular locations.
TLR-4 is a principal signaling receptor for LPS which works synergistically with 
CD14.12   TLR-4 is located at the cell surface as a transmembrane protein, and as such is an 
early interceptor of extracellular PAMPs.  TLR4 (A896G) SNP is located in the 
ectoplasmic domain of the receptor, resulting in an aspartic acid to glycine substitution at 
position 299.  The receptor CD14 is involved in lipopolysaccharide (LPS) signal 
transduction and therefore is essential for interfacing the innate immune system with 
microbial pathogens, as well as directing adaptive immune responses along specific T 
helper differentiation pathways through induction of cytokine expression.11  The signal 
transduction of the LPS/LBP/CD14 ternary complex on effector cells is transferred via 
TLR-4 mediation. Upon stimulation, the TLR-4 complex leads to the activation of innate 
host defense mechanisms via the nuclear factor ΚB (NF-ΚB) pathway and the release of 
proinflammatory cytokines such as TNF-α, IL-1β, IL-6, and interferon-γ.18  Increased 
expression of TLR-4 in gingival tissue from periodontal patients provides evidence that 
TLR-mediated host immune responses may play a role in the periodontal disease process.13   
Additionally, the A896G SNP was shown to be associated with ‘‘an endotoxin 
hyporesponsive phenotype’’ in concert with other genetic changes or acquired factors that 
influence the complex physiological response to LPS.19  Recently, single nucleotide 
polymorphisms in different functional polymorphisms of TLR-4 gene have been described 
that are associated with impaired LPS signal transduction, leading to increased 
susceptibility to infections.20  SNPs in TLR-4 genes were described by Folwaczny21 in 
patients with chronic periodontitis.  Lorenz et al22  found a correlation between TLR-4 and 
presence of gram-negative bacteria. In another study, patients with SNPs in TLR-4 gene
had greater risk of chronic periodontal destruction, but not aggressive periodontitis.20
CD14 C260T SNP is located in the promoter region.  The polymorphism results in 
a cytosine to thymine substitution.19  The SNP CD14-C260T is thought to enhance
4transcriptional activity, and is associated with enhanced monocyte CD14 expression.  
Lipopolysaccharide is internalized by cells through the CD14 receptor.  The CD14 receptor 
is expressed in considerable amounts by mature monocytes, macrophages and activated 
neutrophil granulocytes. In these cells, CD14 is anchored in the cell membrane. In 
addition, the soluble form (sCD14) can be found in plasma in response to LPS stimulation, 
where two major isoforms coexist. Lipopolysaccharide binds to the membrane-bound 
CD14 on monocytes and macrophages and activates these cells. Soluble CD14 plays an 
important role in the LPS-mediated activation of cells lacking membrane-bound CD14, so-
called “CD14-negative cells” (endothelial, epithelial and smooth muscle cells). In addition, 
these CD14-negative cells are activated indirectly by cytokines from LPS-stimulated 
monocytes. But sCD14 can also activate monocytes independently of LPS. Thus, both 
mCD14 and sCD14 are competing for LPS and are able to bind it. Changes in CD14 
expression and plasma sCD14 levels seem to be associated with an increasing number of 
disorders like septicemia23 and periodontitis.24  Recently, research in this field has focused 
on the gene of the CD14 receptor. A polymorphism in the CD14 gene has been reported to 
be associated with increased risk of acute myocardial infarct.25 It was also suggested that 
the C260T change in the promoter region affects the level of CD14 gene expression.26
TLR-2 recognizes many bacterial, fungal, viral, and certain endogenous substances. 
Among these, peptidoglycan and lipoproteins, which are components in the cell walls of 
Gram-positive and Gram-negative bacteria, are the ligands for TLR-2.  TLR-2 is a 
membrane protein, which is expressed on the surface of certain cells and recognizes 
foreign substances and passes on appropriate signals to the cells of the immune system.  
The TLR-2 SNP is located in the exon region, and represents a substitution for Guanine 
with Adenine at position 2408.  It was shown that TLR-2 and TLR-4 are constitutively 
expressed in periodontal tissue and that TLRs can recognize a variety of bacterial 
components.   Studies have found that there is no correlation of TLR-2 polymorphisms and 
chronic periodontitis in Japanese,27 Chinese,28 German,21 or Turkish populations.29
TLR-9 is another toll-like protein responsible for cellular recognition of bacterial 
and viral DNA.16  This receptor is expressed in immune cell rich tissues, such as spleen, 
5lymph node, bone marrow and peripheral blood leukocytes.  The major human cell types 
that express TLR9, and therefore the cells that play a central role in TLR9 signaling, are B 
cells and plasmacytoid dendritic cells.30  TLR-9 has been shown to be expressed in 
intracellular compartments such as endosomes.12  The TLR9 (T1486C) SNP at position 
1486 is located in the promoter region and represents a substitution of cytosine with 
thymine. Bacteria is first non-specifically captured into endosomes, where TLR-9 is 
recruited from the endoplasmic reticulum upon the PAMP uptake.  Bacterial DNA is then 
exposed after degradation of bacteria in phagosomes/lysosomes or endosomes/lysosomes 
in the endoplasmic reticulum. TLR-9 activation then results in release of IL-6 from 
gingival fibroblasts.31    TLR-9 signaling activates dendritic cells to produce 
proinflammatory cytokines and type I interferons (IFNs) through a set of transcription 
factors including NF-kB and IFN regulatory factors (IRFs). Once activated, the action of 
these transcription factors needs to be attenuated and/or terminated to prevent 
immunopathology and maintain tissue homeostasis.32 Without downregulation of the 
transcription factors, increased production and concentration of cytokines in the 
periodontium can lead to loss of periodontal tissue.  In the case of viral infection, viruses 
invade cells by receptor-mediated endocytosis, and the viral contents are exposed to the 
cytoplasm by fusion of the viral membrane and the endosomal membrane. Occasionally, 
the viral particles are degraded in the endosomal compartment, which results in exposure 
of TLR ligands such as dsRNA, ssRNA and CpG DNA.   SNPs in TLR9 have also been 
described and found to be associated with various disease processes, including asthma,33
graft versus host disease,34 and other immune-related inflammatory disorders.35,36  A 2008 
study by Beklen found increased TLR-9 expression in periodontally diseased sites.37  
Additionally, another study by Yamazaki found increased expression of TLR-9 in 
periodontitis when compared with that of gingivitis.38
Fibroblasts, osteoblasts, and cementoblasts are all major components of the human 
periodontium.  A study by Tabeta found that gingival fibroblasts respond to 
periodontopathic bacterial LPS via TLR-2 associated with mCD14 and TLR-4–MD-2 
complex, resulting in the production of proinflammatory cytokines, which can lead to 
6periodontal tissue destruction.39  While the primary role of cementoblasts and osteoblasts is 
to synthesize the components of cementum and bone matrix, respectively, it has been 
reported that osteoblasts exhibit functional expression of TLR-2, TLR-4, and TLR-9; and 
initiate the release of inflammatory cytokines and osteoclastogenesis by activating these 
receptors.   CpG oligodeoxynucleotides interact with osteoblastic TLR-9 and increase the 
expression of molecules regulating osteoclastogenesis.40 Expression of these toll-like 
receptors can lead to increased secretion of inflammatory mediators, resulting in increased 
host periodontal destruction.  In addition to loss of bone supporting the teeth, untreated 
periodontal disease has been associated with various systemic diseases, such as 
cardiovascular disease,41 respiratory disease,42 diabetes,43 and increased risk of preterm 
low birth weight in expectant mothers.44,45  To date, studies investigating the relationship 
between TLR and CD14 gene polymorphisms and periodontal disease did not reach an 
agreement. We know that genetic background can be influenced by racial differences.
The purpose of this study is to determine if a relationship exists between TLR-2, 
TLR-4, TLR-9, or CD14 polymorphisms and risk for developing chronic periodontal 
disease in an African-American population. This is the first study conducted to determine 
role of SNPs in TLR genes and CD14 gene in a periodontally-diseased African-American 
population. Furthermore, this is the first study to assess the role of TLR-9 polymorphism 
in periodontitis patients. Our study provides further information pertaining to genetic 
susceptibility to periodontitis, allowing for earlier therapeutic intervention should an 
individual be determined at risk.  Earlier intervention can prevent further periodontal 
destruction and lead to an overall greater level of health for the individual.
7Methods and Materials
Subjects
A total of 130 African-American subjects between the ages of 29 to 74 years with 
available DNA samples were enrolled in this study. These subjects were divided into 2 
groups:  71 Chronic periodontitis patients, and 59 periodontally healthy controls.  The 
protocol was approved by an institutional review board and all subjects signed a consent 
form to participate in the study.
Chronic periodontitis is defined in this study as displaying at least 4 pockets ≥5mm 
which exhibit bleeding on probing, and at least 1 pocket ≥7mm.  The control group 
consisted of individuals who did not have any periodontal probing depths greater than 
3mm.  The exclusion criteria were: manifestations of systemic disease including cancer, 
atherosclerosis, renal insufficiency, severe asthma, diabetes mellitus, HIV, 
immunosuppression, any patients being prescribed antibiotics for the past 6 months for any 
reason, any patients having systemic conditions that required antibiotic prophylaxis, 
pregnant patients, or any systemic diseases that would alter the course of dental treatment.  
Smoking was classified as current, former, or never smokers.  Former smokers had quit at 
least 6 months ago but not more than 5 years ago, and never smokers had quit more than 5 
years ago. Clinical measurements performed included Plaque Index, probing pocket depth, 
bleeding on probing, and clinical attachment level.  
DNA Extraction and Genetic analysis
Blood was collected from each individual by a trained phlebotomist.  The blood 
was centrifuged, and buffy coats were collected for examination.  Buffy coats were stored 
at -70°C for future use.  DNA was extracted from 200µL of buffy coats using DNA 
extraction kits from QIAGEN following manufacturer’s instructions.
8The SNPs that were investigated are as follows: TLR-2 G2408A (SNP CLUSTER 
ID: rs5743708), TLR-4 A896G (SNP CLUSTER ID: rs4986790), TLR-9 T1486C (SNP 
CLUSTER ID: rs187084), and CD14 C260T (SNP CLUSTER ID: rs2569190).
Genetic analysis was performed with TaqMan SNP assays (Applied Biosystems) 
using Real Time thermocycler AB 7500(Applied Biosystems).  All primers and probes are 
predesigned using Primer Express program (Applied Biosystems) and labeled with VIC 
and FAM fluorescein dyes.  PCR was performed in a volume of 20µL containing 5µL of 
DNA (2-4ng/µL), 13µL of PCR mix containing primers and probes and 2X TaqMan 
Universal PCR MasterMix, No AmpErase UNG(Applied Biosystems), and 2µL of H20.  
The PCR conditions were as follows: Hold step for 10 min at 95°C to allow AmpliTaq 
Gold Enzyme (Applied Biosystems) activation followed by 40 cycles of initial 
denaturation step for 15 seconds at 92°C and annealing and extension step of 1 min at 
60°C. The samples were run on 96-well plates. After completion of PCR amplification, an 
end-point plate reading was performed. Based on the signals generated from each well, 
specific alleles were determined using ABI PRISM Sequence Detection System (SDS) 
software.
To validate the results obtained from real time analysis, PCR-RFLP analyses were 
performed on selected samples using electrophoresis on 2% and 4% agarose gels. PCR 
amplifications were accomplished following published protocols.21,46,47  Table 2 
summarizes the primers, restriction enzymes and conditions for RFLP analysis. 
Statistical analysis.
A thorough statistical power analysis was performed in the program Power and 
Precision Version 2 and was based on the following assumptions:
1) 80%  power, an alpha of 0.05
2) Chi squared goodness of fit test
3) Allele frequencies from published studies
4) Available samples:
a. 71 African American Chronic Periodontitis
b. 59 African American Non-Periodontitis
9The power analysis suggests that meaningful differences could be found in this 
pilot study of existing samples.  The sample size is also sufficient for a basis of power 
analysis for future studies. A Pearson Chi-squared test was used to compare the 
distribution of the different genotypes among periodontally diseased patients versus 
healthy controls.  The frequency of allele carriage and allele frequency in the test versus 
control groups was analyzed using Fisher’s exact test.  All statistics were considered 
statistically significant if they fell outside the 95% CI (p<0.05).  Where significant p-
values were generated, the odds ratio was subsequently calculated.  Illustrative power 
calculations then were performed to estimate the relevance of the p values generated.
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Results
Mean age of the subjects at time of initial examination was 39.71 for chronic 
periodontitis, and 33.75 for periodontally healthy individuals (Table 3).  There were no 
statistically significant differences between the diseased versus the control group for age.
Smoking data was evaluated for the study population based on group classification.  
The distribution of smokers was significantly different between patient groups (p<0.0001), 
therefore all statistical analyses were adjusted for smoking data. (Table 4)
The frequencies of allele distribution within groups is noted in Table 5.  There were 
no statistically significant variations between groups for genotypes of TLR-2 (G2408A), 
TLR-4 (A896G), or CD14 (C260T).  There was, however, a statistically significant 
difference of TLR-9 (C1486T) genotypes between groups (p<0.0001).
The distribution of TLR-9 (C1486 T) genotypes was significantly different between 
the periodontally healthy subjects and the disease group.  The frequency of individuals 
expressing the C allele of TLR-9 polymorphism (CC and CT combined total) was 
significantly higher in the control group (82.46%) compared to the disease group (45.21%) 
(p<0.0001) (Table 6).
The majority of the above mentioned individuals came from families afflicted with 
early onset periodontitis.  Therefore, a question arises about whether the distribution of 
polymorphisms in families was related to being in these particular families.  To investigate 
whether the relationship was related to family membership, TLR-9 distribution was 
analyzed in families with a healthy periodontal diagnosis (Table 7).
Chi squared tests were performed on the TLR-9 distribution data in table 7, and 
showed no statistical significance when familial data was compared.  
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Discussion
The purpose of this study is to determine if the SNPs in TLR-2, -4, -9, and CD14 
genes differ among chronic periodontitis patients and controls in an African American 
population. Our results showed that there was no association between TLR-2, TLR-4, or 
CD14 genetic variants and chronic periodontitis susceptibility. It did, however, show that 
genetic variations at the TLR-9 promoter region (C1486T) containing the C allele (CC & 
CT genotypes) appeared to confer resistance to periodontal destruction in an African 
American population, while subjects homozygous for the T allele were more susceptible to 
chronic periodontitis.  To our knowledge, this result has not been found prior to this study.  
Additionally, this is the first study to look at the role of TLR-9 C1486T SNP in periodontal 
disease.  Another study conducted concurrently with this study evaluated the frequency of 
SNPs in an aggressive periodontitis population of African Americans and compared with 
the same control group, finding similar results. 
The mechanical causes of periodontal disease due to bacterial insult have been well 
established. Several specific bacteria have been implicated as periodontopathogens such as 
A. actinomycetemcomitans, T. denticola, T. forsythensis, P. gingivalis, P. intermedia, and 
F. nucleatum.2,3,4  These bacteria have specific pathologic processes (PAMPs) which can 
elicit a host inflammatory response.12,13,14,15,16,17 Host innate immunity is designed to 
combat pathogenic processes with specific receptors, including TLR-2, TLR-4 , TLR-9, 
and CD14. Bacterial stimulation of TLR-9 (C1486T) stimulates release of cytokines and 
type I interferons (IFNs) through a set of transcription factors including NF-kB and IFN 
regulatory factors (IRFs). Once activated, the action of these transcription factors needs to 
be attenuated and/or terminated to prevent immunopathology and maintain tissue 
homeostasis.32  With increased stimulation of TLR-9 and the NF- kB pathway, further 
release of transcriptional factors can lead to increased destruction of host tissues in the 
absence of proper immunoregulation.32  
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Genetic roles have been implicated for increased risk of individual periodontal 
destruction.9 For example, twin studies conducted at VCU indicate that a significant 
portion of the differences in clinical and radiographic measures of chronic periodontitis 
may be explained by genetic dissimilarity.10  Although it is unlikely that polymorphisms in 
all of these genetic determinants impart differential susceptibility to periodontal disease, it 
is reasonable to expect that multiple genes will be important and that knowledge of these 
may permit determination of individual susceptibility.57
Previous studies have established associations between toll-like receptor expression 
and disease processes, including periodontal disease. Genetic polymorphisms of TLRs can 
be seen in association with disease processes related to asthma,33 graft-versus-host 
disease,34 and arthritis.36 Impaired LPS signal transduction related to single nucleotide 
polymorphisms in TLR4 have been shown to place the host at increased risk of bacterial 
infections.39  Patients with increased levels of SNPs in TLR-4 (C399T) were also found to 
be at greater risk for chronic periodontal destruction.20  Yoshioka found that plaque has an 
ability to stimulate TLR-4 activity, but not TLR-2 activity in gingivitis patients.48  A 
further study conducted by the same group verified that TLR-4 mediated cytokine release 
by blood mononuclear cells was associated with stimulation by periodontopathogenic 
bacteria in plaque.49  Other studies discovered the GG genotype or G-containing genotypes 
of TLR4 as risk markers for periodontitis in Dutch and Finnish patients.50,51 The above 
mentioned results were in direct contrast to our findings, which showed no statistically 
significant relationship between SNP genotype at TLR-2, TLR-4, CD14 and periodontal 
disease susceptibility. This discrepancy could be explained because of a different genetic 
population with differing genetic makeup of these SNPs, or differing study designs with 
varying statistical analysis.
Other investigations have reported findings that are contrary to the above 
mentioned studies, stating that genotype is not associated with disease susceptibility. These 
study results coincide with our results for TLR-2, TLR-4, and CD14.  For example, 
Folwaczny found functional effective mutations of Toll like receptor-2 and -4 genes that 
attenuate the response to PAMPs were equally prevalent among periodontitis patients with 
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any disease severity when compared with healthy control subjects, and reported these 
mutations had no influence on the individual’s susceptibility to periodontitis.21  Schulz 
studied a German population, and was unable to find a correlation between TLR-4 or 
CD14 genotypes and periodontal susceptibility.52  CD14  also did not have any association 
with periodontitis in a Japanese population,53 or the severity of periodontal disease in a 
Czech population.54  CD14 (C260T) genotypes were found to have no significant influence 
on markers of inflammation or risk of coronary artery disease.26  Additionally, studies did 
not find any association between CD14 and aggressive periodontitis, but did find an 
association with TLR-4 and periodontitis in patients living in the UK.55  Our study results 
coincided with the above mentioned publications, finding no statistically significant 
relationship between individual allele genotypes for SNPs in TLR-2, TLR-4, or CD14. 
It has recently been found that TLR-9 expression through stimulation by bacterial 
DNA increases neutrophil adhesion.56  Neutrophil chemotaxis is the initial response in 
periodontal disease to combat periodontopathogenic bacterial aggregates.  The innate 
immune system recognizes nonself, and initiates a host-driven response that results in 
neutrophil chemotaxis to the area of insult.  Neutrophils then phagocytose the pathogenic 
processes (bacterial DNA in this example) for removal.  Bacterial DNA activates NF-ΚB 
in human endothelial cells, the driving force in the initiation and progression of periodontal 
inflammation. Thus, bacterial DNA through TLR-9 promotes neutrophil adherence to 
endothelial cells, induces cytokine release and suppresses neutrophil apoptosis, indicating 
that bacterial DNA is capable of triggering and/or maintaining inflammation even in the 
absence of other bacterial constituents.56   Scaling and root planing can reduce the bacterial 
aggregate, but the bacterial constituents will still be present in the surrounding connective 
tissue as well as the endosomal compartment.  TLR-9 (C1486T) regulation of 
inflammatory response may be genetically driven and have an implication in host 
susceptibility to periodontal destruction.  It can thus be hypothesized that differential 
expression of genes that elicit innate host response to periodontopathogens, such as those 
belonging to the toll-like receptors -2, -4, -9, and CD14, may result in an altered host 
susceptibility to periodontitis.
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Conclusion
Within the limitations of this study, it is suggested that there is not a significant 
relationship between periodontal disease susceptibility in African-Americans whom 
possess genotypic variations of the SNPs of TLR2, TLR4, and CD14 after adjusting for 
age, smoking, and gender variations.  It was, however, suggested through the results that 
African-American individuals whom possess the C allele on TLR9 are conferred a 
resistance to periodontal destruction, as opposed to those possessing the T allele.  
Additional studies with increased sample size are required in order to validate this finding. 
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Tables
Table 1.  Disease conditions attributed to genetically transmitted alterations in 
immune response to microbial infection57
Disease MIM 
number
Gene 
Map 
locus
Inheritance Comments
Leukocyte 
Adhesion 
deficiency type 1
116920 21q22.3 Autosomal 
recessive
Disorder of neutrophil 
function resulting from 
deficiency of beta-2 
integrin subunit of the 
leukocyte cell adhesion 
molecule.
Familial 
disseminated 
atypical 
mycobacterial
infection
209950 2q33-37 Autosomal 
dominant 
resistance 
allele; 
autosomal  
recessive
susceptibility 
allele
Bcg gene is expressed in 
2 allelic forms, a 
dominant resistance 
allele and parasitic 
infection, and affects 
macrophage function.
Chediak-Higashi 
svndrome
214500 1q42.1-
42.2
Autosomal 
recessive
Clinical findings include 
neutropenia and 
abnormal susceptibility 
to infection.
Chronic 
Granulomatous 
disease
306400 Xp21.1 X-linked 
recessive
In this disorder, 
neutrophils can 
phagocytose bacteria but 
cannot kill them in the 
phagocytic vacuoles. 
The cause of the killing 
defect is an inability to 
increase the cell’s 
respiration and 
consequent failure to 
deliver activated oxygen 
into the phagocytic 
vacuole
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Specific granule 
deficiency (also
called
lactoferrin-
deficient
neutrophils)
245480 3q21-q23 Autosomal 
recessive
Lactoferrin has strong 
bacteriostatic properties 
and can deprive bacteria 
of the iron essential for 
growth. It may also 
protect cells from free 
radical damage.  
Patients with specific 
granule deficiency have 
normal
neutrophil counts, but 
have a tissue neutrophil-
specific absence of 
lactoferrin secondary to 
an
abnormality of RNA 
production, possibly due 
to a defective granule-
packaging gene.
Myeloperoxidase 
deficiency
254600 17q12-2 Autosomal 
recessive
Absence of 
myeloperoxidase, a 
dimeric protein that 
catalyzes production of 
intermediates with
microbicidal activity 
against a wide range of 
microbes. Exaggerated 
superoxide production; 
several allelic variants 
have been identified.
Localized 
juvenile 
periodontitis
170650 4qll-113 Autosomal 
dominant
A major gene locus has 
been mapped to 
chromosome 4q. The 
genetic defect is 
unknown
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Table 2.    Primers, restriction enzymes, and conditions for RFLP
SNP Forward 
Primer
Reverse 
Primer
Enzyme Gels Restriction 
Fragments
TLR4 
A896G
5’GAT 
TAG CAT 
ACT TAG 
ACT ACT 
ACC TCC 
ATG 3’
5’GAT 
CAA CTT 
CTG AAA 
AAG CAT 
TCC CAC
3’
10U/µl Nco I at 
37C overnight 
in 1.5 µl 10 X 
restriction 
buffer and 1.3 
µl water
3% NuSieve 
gel or 4% 
MetaPhor 
agarose gel 
stained with 
ethidium 
bromide
Wild type 
(alleleA) 
249bp
Asp299Gly(a
lleleG)223+2
6bp
TLR2 
A2408G
5’ CAT 
TCC CCA  
GCG CTT 
CTG CAA 
GCT CC 
3’
5’ GGA 
ACC TAG 
GAC TTT 
ATC GCA 
GCT C 3’
Msp I at 37C 2% agarose 
gel
Wild type 
(allele G)
104b
p + 25bp
Arg753Gln(a
llele A) 
129bp
TLR9 
T1486C
5’ TCC 
CAG CAG 
CAA CAA 
TTC ATT 
A 3’
5’ CTG 
CTT GCA 
GTT GAC 
TGT GT 3’
20U of AflII 
(New England 
Biolabs) at 37C 
overnight
2% agarose 
70 min at 
75V
Wild type 
327 and 172 
bp
Mutant
499b
p
CD14 
C260T
5' GGT 
GCC AAC 
AGA TGA 
GGT TCA 
C3'
5 CTT CGG 
CTG CCT 
CTG ACA 
GTT-3
HaeIII 2% & 4% 
agarose
Wild type 
159
Mutant                
260
Table 3.  Demographics data of the groups (age):
Disease 
Classification
Number Age at initial examination Age at final 
examination
Chronic 
periodontitis
73 39.71 ± 0.87 42.55 ± 0.67
Periodontally 
healthy
57 33.75 ± 1.23 37.81 ± 0.99
Ages of individuals at time of initial examination compared with age at final examination.
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Table 4.  Smoking data by disease classification
Classification Chronic periodontitis Periodontally healthy Totals
Former smoker 12
16.90
8
14.55
20
Never smoker 28
39.44
40
72.73
68
Undetermined 4
5.63
1
1.82
5
Current smoker 27
38.03
6
10.91
33
Totals 71 55 126
Smoking data represented by questionnaire and interview of patients at time of periodontal 
examination by examiners in prior Virginia Commonwealth University study.
Table 5.  Genotype frequency of TLR2, TLR4, TLR9, and CD14 between groups
Polymor
phisms
Geno
type
CP n (%) NP n (%) Allele CP 2n (%) NP 2n  (%)
TLR2
(G2408A)
GG
GA
AA
69 (98.57)
0 (0)
1 (1.43)
2 (3.57)
3 (5.36)
51 (91.07)
G
A
138 (98.6)
2 (1.4)
7 (6.3)
105 (93.7)
TLR4
(A896G)
AA
AG
GG
62 (84.93)
8 (10.96)
3 (4.11)
44 (83.02)
7 (13.21)
2 (3.77)
A
G
132 (90.4)
14 (9.6)
95 (89.6)
11 (10.4)
TLR9 
(C1486T)
CC
CT
TT
12 (16.44)
21 (28.77)
40 (54.79)
4 (7.02)
43 (75.44)*
10 (17.54)*
C
T
45 (30.8)
101 (69.2)
51 (44.74)
63 (55.26)
CD14
(C260T)
TT
CT
CC
6 (15.79)
25 (65.79)
7 (18.42)
4(8.00)
36 (72.00)
10 (20.00)
C
T
37 (48.7)
39 (51.3)
44 (44)
56 (56)
*p<0.0001  
Genotype  and allele frequencies for all SNPs investigated.  n(%) values show frequency of 
genotype, first in raw number, followed by individual group percentage.  2n(%) values 
show frequency of each investigated allele, in the same format as n(%).
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Table 6. TLR-9 Genotypes (CT or CC) Versus  TT 
Genotype Chronic periodontitis Periodontally healthy Totals
CC + CT 33
45.21
47
82.46*
80
TT 40
54.79
10
17.54*
50
Totals 73 57 130
*p<0.0001.
Genotype of CC + CT frequency compared in chronic periodontitis group versus healthy 
controls. 
Table 7.  TLR-9 genotype distribution within families
Genotype No familial relation Familial relation Totals
CC 2
10.00
2
5.41
4
CT 14
70.00
29
78.38
43
TT 4
20.00
6
16.22
10
Totals 20 37 57
Genotypes compared when occurring in same family versus different genetic lineage.
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